MedTrace Logo

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

NCT03551769 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-05-29

No results posted yet for this study

Summary

This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects.

Conditions

  • Alzheimer Disease

Interventions

DRUG

tricaprilin

Tricaprilin formulated as AC-SD-01

OTHER

standard meal

standard meal

OTHER

high-fat meal

high-fat meal

OTHER

overnight fast

fasting for at least 9 hours

Sponsors & Collaborators

  • Cerecin

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-05
Primary Completion
2018-08-16
Completion
2018-08-27
FDA Drug
Yes

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03551769 on ClinicalTrials.gov